GlassScriptPhysician profile
Jonathan A Israel
NPI 1407122427
$6,980.07
in general payments reported to CMS, 2019-2025
27 companies · $1,055 in 2025
The $1,055 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,126 · 2020: $3,068 · 2021: $151 · 2022: $184 · 2023: $167 · 2024: $229 · 2025: $1,055.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $974 · Travel and Lodging: $478.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $973.68 |
| Travel and Lodging | $477.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,299.38 | 2019-2020 | |
| Angiodynamics, INC. | $477.96 | 2025 | Nanoknife |
| Teleflex LLC | $304.97 | 2021-2025 | Barrigel, Urolift |
| Astellas Pharma US INC | $254.23 | 2019-2020 | |
| Janssen Biotech, INC. | $233.77 | 2023-2025 | Rybrevant, Carvykti, Erleada |
| Neotract INC. | $220.78 | 2019-2020 | |
| Abbvie INC. | $219.19 | 2019-2025 | |
| Coloplast Corp | $154.06 | 2019-2025 | |
| Astellas Pharma Global Development | $131.55 | 2025 | Xtandi |
| Dendreon Pharmaceuticals LLC | $112.12 | 2019 | |
| Pfizer INC. | $79.78 | 2019-2020 | |
| Tolmar Pharmaceuticals, INC. | $53.70 | 2019 | |
| Sumitomo Pharma America, INC. | $53.30 | 2025 | Gemtesa |
| Calyxo, INC. | $45.00 | 2025 | Cvac Aspiration System |
| Medtronic, INC. | $44.91 | 2023-2024 | Interstim |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $41.03 | 2022 | |
| Janssen Scientific Affairs, LLC | $39.13 | 2019 | |
| Verity Pharmaceuticals INC. | $37.68 | 2025 | Trelstar |
| Boston Scientific Corporation | $33.55 | 2023-2025 | Axonics, Rezum Generator |
| Vertex Pharmaceuticals Incorporated | $29.13 | 2024 | |
| Ambu INC. | $23.76 | 2025 | |
| Blue Earth Diagnostics | $18.64 | 2024 | |
| Stryker Corporation | $16.82 | 2025 | 1788 |
| Rochester Medical Corporation | $16.45 | 2019 | |
| 180 Medical, INC. | $14.96 | 2019 | |
| Laborie Medical Technologies Corp. | $12.37 | 2025 | |
| Endo Pharmaceuticals INC. | $11.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Israel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.